Skip to main content
Clinical Trials/NCT04984928
NCT04984928
Unknown
N/A

Predicting the Risk of Readmission in Patients With Chronic Heart Failure

University Hospital, Montpellier1 site in 1 country1,500 target enrollmentSeptember 20, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic Heart Failure
Sponsor
University Hospital, Montpellier
Enrollment
1500
Locations
1
Primary Endpoint
30 days all cause readmission rate
Last Updated
4 years ago

Overview

Brief Summary

Heart failure (HF) is a frequent, serious, and costly chronic disease: it leads to 150,000 hospitalizations each year in France at a cost of 525 million Euros.

It is estimated that 20-40% of these hospitalizations are preventable by known interventions: home telemonitoring, care coordination, therapeutic intensification and therapeutic education. But these interventions only work if patients at high risk of rehospitalization are targeted to individualize management. In these patients, the risk of rehospitalization depends on clinical, biological, socioeconomic, care pathway, and location-related data. Existing predictive tools perform poorly due to three important limitations: non-use of unstructured clinical data, lack of integration of multimodal data, and weakness of the algorithmic approach.

The objective is to design and validate a predictive algorithm for the risk of rehospitalization in heart failure patients, using multiple data sources

Registry
clinicaltrials.gov
Start Date
September 20, 2021
End Date
December 30, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

30 days all cause readmission rate

Time Frame: day 30

30 days all cause readmission rate

Secondary Outcomes

  • 90 days all cause readmission rate(day 90)

Study Sites (1)

Loading locations...

Similar Trials